Regardless of amplification, ALK overexpression is widely observed in nearly 100% of basal cell carcinoma [25] and in more than 50% of neuroblastomas, with only 10% of primary neuroblastomas displaying also ALK gene amplification. Here, ALK is linked to basal cell carcinoma.